Cambridge NeuroScience, The Gladstone Institute of Cardiovascular Disease, University of California deal

CNSI formed Cambridge NeuroScience Partners, which will manage a drug discovery and development program in Alzheimer’s disease

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE